Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arbrook was a prominent healthcare company and a subsidiary of Johnson & Johnson that specialized in infection control and sterilization products. The company is most notably recognized for developing and commercializing CIDEX (glutaraldehyde), which became a global standard for the high-level disinfection of heat-sensitive medical and surgical instruments. In addition to chemical sterilants, Arbrook manufactured surgical gloves and other protective medical supplies. Its operations were eventually integrated into other Johnson & Johnson divisions, specifically Surgikos, and later became part of Advanced Sterilization Products (ASP).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arbrook.